Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06184672 |
Other study ID # |
008 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
February 8, 2024 |
Est. completion date |
March 12, 2024 |
Study information
Verified date |
January 2024 |
Source |
Sierra Varona SL |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
ChatGPT ChatGPT Injury prevention and performance enhancement have become two of the main
goals in every sport. Myofascial Pain Syndrome is primarily caused by myofascial trigger
points, which may result in referred pain, stiffness, shortening, and/or muscle weakness.
The aim of this study is to assess the effects of dry needling on latent myofascial trigger
points (LTMTP) and its impact on vertical jump height in female volleyball players.
The study is a single-blind, randomized controlled clinical trial conducted on healthy female
volleyball practitioners with no lower limb injuries in the last 6 months. Participants must
exhibit LMTP in the triceps surae muscles and be familiar with the counter-movement jump
(CMJ) test. Subjects will be randomly assigned to either a control group or an intervention
group.
Description:
This study will be a single-blind, randomized clinical trial conducted in the Department of
Invasive Physiotherapy at a private Physiotherapy Clinic in Toledo.
The inclusion criteria are as follows: healthy female volleyball practitioners with no lower
limb injuries in the last 6 months, the presence of latent MTPs in the gastrocnemius, and
familiarity with performing CMJ tests. Subjects will not be eligible for the study if they
have needle phobia, active MTPs in the lower limb, any pathology preventing the use of dry
needling, or any pathology preventing the performance of the CMJ test.
Subjects will be randomly assigned to two groups: the intervention group and the control
group. Sealed cards containing numbers 1 to 24 in opaque envelopes will be provided, and
participants will randomly select a card. Odd-numbered subjects will become part of the
control group, while subjects with even numbers will be part of the intervention group.
All subjects must sign a copy of the consent form, which describes and explains the
objectives and procedures of the study.
Both groups will undergo a standard warm-up session, including continuous running, dynamic
lower limb stretching, and vertical jumps, lasting for 10 minutes (T0). Following the
warm-up, the principal investigator will administer the dry needling technique to those
assigned to the experimental group. The second measurement will be conducted immediately
after the needling technique (T1). Participants in the control group will be instructed to
wait on the intervention couch for a comparable duration to those receiving treatment.
The third and fourth assessments will take place in the same clinical setting approximately
72 hours (T3) and 7 days (T4) later, respectively. At each study point, participants will
perform 3 CMJ tests. The CMJ-style jumps will be recorded using the high-speed camera of the
iPhone 15 (Apple Inc., USA). The My Jump app, validated with a force platform, will calculate
the flight time by identifying the subject's takeoff and landing, utilizing an equation from
the literature. The best of the three jumps will be recorded. The assessor will be blinded to
the allocation group of the participants